A Shake&Read distance-based microfluidic chip as a portable quantitative readout device for highly sensitive point-of-care testing

2016 ◽  
Vol 52 (91) ◽  
pp. 13377-13380 ◽  
Author(s):  
Yi Xie ◽  
Xiaofeng Wei ◽  
Qizhen Yang ◽  
Zhichao Guan ◽  
Dan Liu ◽  
...  

We developed a Shake&Read distance-based microfluidic chip for simple, disposable, equipment-free, visual and quantitative POCT.

2021 ◽  
Author(s):  
Binfeng Yin ◽  
Xinhua Wan ◽  
Mingzhu Yang ◽  
Changcheng Qian ◽  
A S M Muhtasim Fuad Sohan

Abstract Background: Simultaneous and timely detection of C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6) provides effective information for the accurate diagnosis of infections. Early diagnosis and classification of infections increase the cure rate while decreasing complications, which is significant for severe infections, especially for war surgery. However, traditional methods rely on laborious operations and bulky devices. On the other hand, point-of-care (POC) methods suffer from limited robustness and accuracy. Therefore, it is of urgent demand to develop POC devices for rapid and accurate diagnosis of infections to fulfill on-site militarized requirements.Methods: We developed a wave-shaped microfluidic chip (WMC) assisted multiplexed detection platform (WMC-MDP). WMC-MDP reduces detection time and improves repeatability through premixing of the samples and reaction of the reagents. We further combined the detection platform with the streptavidin-biotin (SA-B) amplified system to enhance the sensitivity while using chemiluminescence (CL) intensity as signal readout. We realized simultaneous detection of CRP, PCT, and IL-6 on the detection platform and evaluated the sensitivity, linear range, selectivity, and repeatability. Finally, we finished detecting 15 samples from volunteers and compared the results with commercial ELISA kits.Results: Detection of CRP, PCT, and IL-6 exhibited good linear relationships between CL intensities and concentrations in the range of 1.25-40 μg/mL, 0.4-12.8 ng/mL, and 50-1600 pg/mL. The limit of detection (LOD) of CRP, PCT, and IL-6 were 0.54 μg/mL, 0.11 ng/mL, and 16.25 pg/mL, respectively. WMC-MDP is capable of good adequate selectivity and repeatability. The whole detection procedure takes only 22 minutes that meets the requirements of a POC device. Results of 15 samples from volunteers were consistent with the results detected by commercial ELISA kits.Conclusion: WMC-MDP allows simultaneous, rapid, and sensitive detection of CRP, PCT, and IL-6 with satisfactory selectivity and repeatability, requiring minimal manipulation. However, WMC-MDP takes advantage of being a microfluidic device showing the coefficients of variation less than 10% enabling WMC-MDP to be a type of POCT. Therefore, WMC-MDP provides a promising alternative to point-of-care testing (POCT) of multiple biomarkers. We believe the practical application of WMC-MDP in militarized fields will revolutionize infection diagnosis for soldiers.


The Analyst ◽  
2021 ◽  
Author(s):  
Ling Li ◽  
Hanwen Deng ◽  
Zhongshuai Zhao ◽  
Zhongde Liu

On the basis of the target-responsive aggregation occurrence of Au@PtNPs, a pressure-based signaling strategy was developed for highly sensitive and specific melamine detection not only in laboratory but also in point-of-care (POC) settings.


2015 ◽  
Vol 7 (2) ◽  
pp. 025007 ◽  
Author(s):  
Hojjat Madadi ◽  
Jasmina Casals-Terré ◽  
Mahdi Mohammadi

Talanta ◽  
2021 ◽  
Vol 224 ◽  
pp. 121844
Author(s):  
Peng Chen ◽  
Chen Chen ◽  
Huiying Su ◽  
Mengfan Zhou ◽  
Shunji Li ◽  
...  

Lab on a Chip ◽  
2017 ◽  
Vol 17 (6) ◽  
pp. 1051-1059 ◽  
Author(s):  
Andrew S. Paterson ◽  
Balakrishnan Raja ◽  
Vinay Mandadi ◽  
Blane Townsend ◽  
Miles Lee ◽  
...  

Time-gated imaging on a smartphone of a lateral flow test strip run with persistent luminescent nanophosphors.


Biosensors ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 295
Author(s):  
Wesley Wei-Wen Hsiao ◽  
Trong-Nghia Le ◽  
Dinh Minh Pham ◽  
Hui-Hsin Ko ◽  
Huan-Cheng Chang ◽  
...  

The development of reliable and robust diagnostic tests is one of the most efficient methods to limit the spread of coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, most laboratory diagnostics for COVID-19, such as enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase-polymerase chain reaction (RT-PCR), are expensive, time-consuming, and require highly trained professional operators. On the other hand, the lateral flow immunoassay (LFIA) is a simpler, cheaper device that can be operated by unskilled personnel easily. Unfortunately, the current technique has some limitations, mainly inaccuracy in detection. This review article aims to highlight recent advances in novel lateral flow technologies for detecting SARS-CoV-2 as well as innovative approaches to achieve highly sensitive and specific point-of-care testing. Lastly, we discuss future perspectives on how smartphones and Artificial Intelligence (AI) can be integrated to revolutionize disease detection as well as disease control and surveillance.


Author(s):  
Maria João Oliveira ◽  
Inês Cunha ◽  
Miguel Peixoto de Almeida ◽  
Tomás Calmeiro ◽  
Elvira Fortunato ◽  
...  

The development of robust and sensitive point-of-care testing platforms is necessary to improve patient care and outcomes. Surface-Enhanced Raman Scattering (SERS)-based immunosensors are especially suited for this purpose. Here, we...


Lab on a Chip ◽  
2019 ◽  
Vol 19 (10) ◽  
pp. 1797-1807 ◽  
Author(s):  
Chao Liang ◽  
Yuanchang Liu ◽  
Aiying Niu ◽  
Chong Liu ◽  
Jingmin Li ◽  
...  

We present a smartphone-app platform for point-of-care testing of cTnI, which features the self-aligned on-chip focusing (SOF) lenses for enhancing the fluorescence intensity.


Sign in / Sign up

Export Citation Format

Share Document